Journal
DIABETOLOGIA
Volume 52, Issue 12, Pages 2633-2641Publisher
SPRINGER
DOI: 10.1007/s00125-009-1548-8
Keywords
Diabetic retinopathy; Human study; Interphotoreceptor retinoid-binding protein; Neurodegeneration; Retina; Vitreous fluid
Categories
Funding
- Novo Nordisk Pharma, the Ministerio de Ciencia e Innovacion ( MCIN) [SAF2006-05284, SAF2009-07408]
- Fundacion para la Diabetes and the Generalitat de Catalunya [2005SGR- 00030]
- CIBERDEM
Ask authors/readers for more resources
Interphotoreceptor retinoid-binding protein (IRBP) plays a major role in the visual cycle and is essential to the maintenance of photoreceptors. The aim of this study was to determine whether a decrease in IRBP production exists in the early stages of diabetic retinopathy. Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot. Human post mortem eyes (n = 16) from diabetic donors without clinically detectable retinopathy and from non-diabetic donors (n = 16) were used to determine IRBP (also known as RBP3) mRNA levels (RT-PCR) and protein content (western blot and confocal microscopy). Retinal neurodegeneration was assessed by measuring glial fibrillar acidic protein (GFAP) and the apoptotic rate. Y79 human retinoblastoma cells were used to test the effects of glucose, TNF-alpha and IL-1 beta on IRBP expression and IRBP levels. Intravitreous IRBP concentration was significantly lower in PDR < NPDR < control in proteomic and western blot analysis. IRBP mRNA levels and IRBP protein content were significantly lower in the retinas from diabetic donors than in those from non-diabetic donors. Increased GFAP and a higher degree of apoptosis were observed in diabetic retinas compared with non-diabetic retinas. A dose-dependent downregulation of IRBP mRNA expression and IRBP content was detected with glucose, TNF-alpha and IL-1 beta in cultures of Y79 human retinoblastoma cells. Underproduction of IRBP is an early event in the human diabetic retina and is associated with retinal neurodegeneration. The mechanisms leading to this deficit deserve further investigation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available